June 27, 2013
1 min read

Victus laser platform granted license for cataract, refractive procedures in Canada

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Health Canada issued a medical device license for the Victus femtosecond laser platform, according to a news release.

The license allows the Victus platform (Bausch + Lomb Technolas) to be used for the creation of a corneal flap during LASIK surgery, anterior capsulotomy in cataract surgery, penetrating arcuate cuts or incisions in the cornea, and laser-assisted lens fragmentation during cataract surgery, the release said.

The Victus platform first earned a CE mark in November 2011 and was cleared by the U.S. Food and Drug Administration in July 2012.

In April, the platform was granted a CE mark for creating corneal incisions in patients undergoing cataract surgery and creating intrastromal channel incisions for intracorneal ring segments, as well as for penetrating keratoplasty.